A Phase 1B Dose-escalation Study of TRC105 in Combination With Axitinib in Patients With Advanced Renal Cell Carcinoma

Sponsors and Collaborators
Tracon Pharmaceuticals Inc.

Contact
Bonne Adams
[email protected]

Manoj Jivani
[email protected]


Continue Reading

ClinicalTrials.gov Identifier
NCT01806064